UnitedHealth Group Option Alert: Mar 20 $300 Calls Sweep (3) near the Bid: 250 vs 2725 OI; Earnings 7/29 Before Open 

UnitedHealth Group Option Alert: Mar 20 $300 Calls Sweep (3) near the Bid: 250 @ $48.701 vs 2725 OI; Earnings 7/29 Before Open Ref=$307.29

UnitedHealth Group Option Alert: Mar 20 $300 Calls at the Bid: 500 vs 2725 OI; Earnings 7/29 Before Open 

UnitedHealth Group Option Alert: Mar 20 $300 Calls at the Bid: 500 @ $48.7 vs 2725 OI; Earnings 7/29 Before Open Ref=$307.09

UnitedHealth Group Option Alert: Mar 20 $300 Calls at the Ask: 500 vs 2725 OI; Earnings 7/29 Before Open 

UnitedHealth Group Option Alert: Mar 20 $300 Calls at the Ask: 500 @ $48.0 vs 2725 OI; Earnings 7/29 Before Open Ref=$306.73

UnitedHealth Group Option Alert: Dec, 2027 $290 Puts at the Bid: 120 vs 21 OI; Earnings 7/29 Before Open 

UnitedHealth Group Option Alert: Dec, 2027 $290 Puts at the Bid: 120 @ $58.75 vs 21 OI; Earnings 7/29 Before Open Ref=$301.79

UnitedHealth Group Option Alert: Dec 19 $500 Puts Sweep (6) near the Bid: 41 vs 108 OI; Earnings 7/29 Before Open 

UnitedHealth Group Option Alert: Dec 19 $500 Puts Sweep (6) near the Bid: 41 @ $197.5 vs 108 OI; Earnings 7/29 Before Open Ref=$300.675

UnitedHealth Group Option Alert: Jun, 2026 $350 Calls at the Bid: 700 vs 1525 OI; Earnings 7/29 Before Open 

UnitedHealth Group Option Alert: Jun, 2026 $350 Calls at the Bid: 700 @ $31.5 vs 1525 OI; Earnings 7/29 Before Open Ref=$299.5145

UnitedHealth Group Option Alert: Sep 19 $550 Puts at the Bid: 80 vs 18 OI; Earnings 7/29 Before Open 

UnitedHealth Group Option Alert: Sep 19 $550 Puts at the Bid: 80 @ $246.36 vs 18 OI; Earnings 7/29 Before Open Ref=$302.89

UnitedHealth Group Option Alert: Jul 18 $430 Puts at the Bid: 70 vs 55 OI; Earnings 7/29 Before Open 

UnitedHealth Group Option Alert: Jul 18 $430 Puts at the Bid: 70 @ $126.75 vs 55 OI; Earnings 7/29 Before Open Ref=$302.89

UnitedHealth Group Option Alert: Aug 15 $510 Puts at the Bid: 130 vs 31 OI; Earnings 7/29 Before Open 

UnitedHealth Group Option Alert: Aug 15 $510 Puts at the Bid: 130 @ $206.83 vs 31 OI; Earnings 7/29 Before Open Ref=$302.89

UnitedHealth Group Option Alert: Aug 15 $500 Puts at the Bid: 120 vs 30 OI; Earnings 7/29 Before Open 

UnitedHealth Group Option Alert: Aug 15 $500 Puts at the Bid: 120 @ $197.23 vs 30 OI; Earnings 7/29 Before Open Ref=$302.89

UnitedHealth Group Option Alert: Sep 19 $540 Puts at the Bid: 1180 vs 257 OI; Earnings 7/29 Before Open 

UnitedHealth Group Option Alert: Sep 19 $540 Puts at the Bid: 1180 @ $236.87 vs 257 OI; Earnings 7/29 Before Open Ref=$302.8883

UnitedHealth Group Option Alert: Sep 19 $580 Puts at the Bid: 150 vs 39 OI; Earnings 7/29 Before Open 

UnitedHealth Group Option Alert: Sep 19 $580 Puts at the Bid: 150 @ $276.76 vs 39 OI; Earnings 7/29 Before Open Ref=$302.8883

UnitedHealth Group Option Alert: Jan 16 $610 Puts at the Bid: 190 vs 30 OI; Earnings 7/29 Before Open 

UnitedHealth Group Option Alert: Jan 16 $610 Puts at the Bid: 190 @ $306.41 vs 30 OI; Earnings 7/29 Before Open Ref=$302.8883

UnitedHealth Group Option Alert: Jul 18 $520 Puts at the Bid: 34 vs 5 OI; Earnings 7/29 Before Open 

UnitedHealth Group Option Alert: Jul 18 $520 Puts at the Bid: 34 @ $214.25 vs 5 OI; Earnings 7/29 Before Open Ref=$303.05

UnitedHealth Group Option Alert: Jan 16 $480 Puts at the Bid: 45 vs 776 OI; Earnings 7/29 Before Open 

UnitedHealth Group Option Alert: Jan 16 $480 Puts at the Bid: 45 @ $176.6 vs 776 OI; Earnings 7/29 Before Open Ref=$303.5417

UnitedHealth Group Option Alert: Jan 16 $480 Puts at the Bid: 49 vs 776 OI; Earnings 7/29 Before Open 

UnitedHealth Group Option Alert: Jan 16 $480 Puts at the Bid: 49 @ $173.85 vs 776 OI; Earnings 7/29 Before Open Ref=$303.81

UnitedHealth Group (NYSE:UNH) Stock

UNITEDHEALTH GROUP INC

UnitedHealth Group

UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Shares of managed care provider Centene Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>) dropped over 40% on Wednesday, marking the worst single-day performance in the company's history.
Check out the current price of&nbsp;<a href="https://www.benzinga.com/quote/CNC" target="_blank" rel="noreferrer noopener">CNC stock here.</a>
What Happened: On CNBC&#8217;s Mad Money, Jim Cramer referred to the collapse as &#8220;a huge hit,&#8221; resulting from a combination of factors such as weak Affordable Care Act enrollments, an actuarial report pointing to sicker patients, and the company&#8217;s decision to <a href="https://www.benzinga.com/markets/guidance/25/07/46209736/centene-withdraws-2025-guidance-shares-dive">pull its 2025 outlook</a>.
&#8220;Companies make forecasts, they&#8217;re supposed to try and beat them,&#8221; Cramer says, however, &#8220;they rarely pull them.&#8221;
According to Cramer, Centene disclosed data from an independent actuarial firm covering 22 of the 29 states where it operates ACA exchange plans.
See Also: <a href="https://www.benzinga.com/markets/macro-economic-events/25/07/46195080/doj-dismantles-14-billion-healthcare-fraud-scheme-in-largest-ever-crackdown-impacting-over-1-million-americans">DOJ Dismantles $14 Billion Healthcare Fraud Scheme In Largest-Ever Crackdown, Impacting Over 1 Million Americans</a>
The findings showed that overall marketplace enrollment growth was lower than expected and that those who did enroll were in poorer health than projected, a combination that significantly affects the company's bottom line, thus prompting the company to pull its guidance.
As a result, the company now expects a $1.8 billion reduction in its projected risk adjustment revenue from the federal government. This drop is expected to slash its 2025 earnings by $2.75 per share.
&#8220;This is horrifying,&#8221; Cramer said, referring to the sharp revision in Centene&#8217;s EPS, from $7.25 per share projected earlier. &#8220;We&#8217;re talking about a 35% to 40% hit to their numbers,&#8221; Cramer says, &#8220;no wonder the stock was eviscerated.&#8221;
Why It Matters: Centene&#8217;s decision to withdraw its guidance, citing the independent actuarial report, led to a sector-wide selloff on Wednesday. 
All of Centene&#8217;s peers and competitors in the managed care business, such as Molina Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>), Elevance Health Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELV#NYSE">ELV</a>), UnitedHealth Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>), and Cigna Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>), among others, all falling in tandem during the day. 
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td class="has-text-align-center" data-align="center">Stocks / ETFs</td>
<td class="has-text-align-center" data-align="center">1 Day</td>
<td class="has-text-align-center" data-align="center">Year-To-Date</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Centene Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>)</td>
<td class="has-text-align-center" data-align="center">-40.37%</td>
<td class="has-text-align-center" data-align="center">-44.17%</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Molina Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>)</td>
<td class="has-text-align-center" data-align="center">-21.97%</td>
<td class="has-text-align-center" data-align="center">-16.79%</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Elevance Health Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELV#NYSE">ELV</a>)</td>
<td class="has-text-align-center" data-align="center">-11.50%</td>
<td class="has-text-align-center" data-align="center">-4.26%</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">UnitedHealth Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>)</td>
<td class="has-text-align-center" data-align="center">-5.70%</td>
<td class="has-text-align-center" data-align="center">-39.04%</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Cigna Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>)</td>
<td class="has-text-align-center" data-align="center">-4.19%</td>
<td class="has-text-align-center" data-align="center">+16.72%</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">iShares US Healthcare Providers ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IHF#NYSE">IHF</a>)</td>
<td class="has-text-align-center" data-align="center">-6.27%</td>
<td class="has-text-align-center" data-align="center">-3.16%</td>
</tr>
</tbody>
</table>
</figure>
This comes amid a potential amendment in the Affordable Care Act, which could lead to an additional $313 billion in <a href="https://www.benzinga.com/markets/macro-economic-events/25/06/46163659/senate-republicans-propose-313-billion-cut-in-medicaid-spending-in-trumps-big-beautiful-bill">spending cuts</a> by blocking able-bodied adults without dependent children in Medicaid expansion states from receiving the enhanced 9-to-1 Federal Medical Assistance Percentage (FMAP).
Insurers have also <a href="https://www.benzinga.com/personal-finance/tax/25/06/46012776/brace-for-higher-healthcare-premiums-in-2026-as-insurers-blame-trumps-tariffs-in-filings-to-regulators-report">warned of higher premiums</a> in 2026, placing the blame on President Donald Trump&#8217;s tariffs, which are expected to increase the cost&nbsp;of prescription drugs, medical devices,&nbsp;and other medical products and&nbsp;services.
Price Action: Shares of Centene dropped 40.37% on Wednesday, closing at $33.78, but are up 1.10% after hours.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="143" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02234828/Screenshot-2025-07-03-at-9.18.15-AM-1024x143.png" alt="" class="wp-image-971299" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02234828/Screenshot-2025-07-03-at-9.18.15-AM-1024x143.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02234828/Screenshot-2025-07-03-at-9.18.15-AM-300x42.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02234828/Screenshot-2025-07-03-at-9.18.15-AM-768x107.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02234828/Screenshot-2025-07-03-at-9.18.15-AM.png 1532w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
According to Benzinga&#8217;s Edge Stock Rankings, Centene scores well on Value and Growth, but has an unfavorable price trend in the short, medium and long term. Click <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">here</a> for deeper insights on the stock, as well as its peers and competitors in the managed care space.
Photo courtesy: katz / Shutterstock.com
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/personal-finance/management/25/06/46166087/mark-cuban-slams-insurers-over-high-deductibles-urges-josh-hawley-to-change-the-game-with-two-part-plan">Mark Cuban Slams Insurers Over High Deductibles, Urges Josh Hawley To &#8216;Change The Game&#8217; With Two-Part Plan</a></li>
</ul>

News

Guidance

Markets

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

iShares Dow Jones US Health Care Provides Index Fund

Jim Cramer On Centene's 40% Crash: Fewer ACA Signups, Sicker Patients, Pulled Guidance And Major Earnings Hit Trigger Selloff: 'This Is Horrifying'

Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0702" target="_blank" rel="noreferrer noopener">&nbsp;and individual tickers.</a>
The 2025 year is half over with July now here, which is likely hard for many to believe. Here is a look at the most searched stocks on Benzinga Pro for the first half of 2025. Current prices and year-to-date performance are based on June 30 market close prices and do not include dividends.
1. SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)
<ul class="wp-block-list">
<li>Current Price: $617.85</li>
<li>52-Week Range: $481.81 to $619.22</li>
<li>Year-to-Date Return: +5.7%</li>
<li><a href="https://www.benzinga.com/trading-ideas/25/01/42802731/exclusive-top-20-most-searched-tickers-on-benzinga-pro-in-2024-where-do-tesla-nvidia-gamestop-trump-media-stocks-rank">2024 Benzinga Pro Search Rank</a>: 3rd</li>
<li><a href="https://www.benzinga.com/trading-ideas/25/05/45171636/exclusive-aprils-20-most-searched-tickers-on-benzinga-pro-where-do-tesla-apple-palantir-nvidia-stocks-rank">April</a>/<a href="https://www.benzinga.com/trading-ideas/long-ideas/25/06/45750724/exclusive-mays-20-most-searched-tickers-on-benzinga-pro-where-do-apple-palantir-coreweave-nvidia-rank">May</a>/<a href="https://www.benzinga.com/trading-ideas/long-ideas/25/07/46205646/exclusive-june-20-most-searched-tickers-on-benzinga-pro-where-do-coreweave-nvidia-apple-stock-rank">June </a>2025 Search Rank: 1st/1st/1st</li>
</ul>
2. Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)
<ul class="wp-block-list">
<li>Current Price: $317.66</li>
<li>52-Week Range: $182 to $488.54</li>
<li>Year-to-Date Return: -16.3%</li>
<li>2024 Benzinga Pro Search Rank: 2nd &nbsp;</li>
<li>April/May/June 2025 Search Rank: 3rd/4th/2nd</li>
</ul>
3. NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)
<ul class="wp-block-list">
<li>Current Price: $157.99</li>
<li>52-Week Range: $86.63 to $158.71</li>
<li>Year-to-Date Return: +14.2%</li>
<li>2024 Benzinga Pro Search Rank: 1st</li>
<li>April/May/June 2025 Search Rank: 2nd/2nd/3rd</li>
</ul>
4. Palantir Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>)
<ul class="wp-block-list">
<li>Current Price: $136.32</li>
<li>52-Week Range: $21.23 to $148.22</li>
<li>Year-to-Date Return: +81.3%</li>
<li>2024 Benzinga Pro Search Rank: 7th</li>
<li>April/May/June 2025 Search Rank: 7th/3rd/4th</li>
</ul>
5. Hims &amp; Hers Health Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>)
<ul class="wp-block-list">
<li>Current Price: $49.85</li>
<li>52-Week Range: $13.47 to $72.98</li>
<li>Year-to-Date Return: +97.8%</li>
<li>2024 Benzinga Pro Search Rank: Not in Top 20</li>
<li>April/May/June 2025 Search Rank: 8th/9th/8th</li>
</ul>
6. UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>)
<ul class="wp-block-list">
<li>Current Price: $311.97</li>
<li>52-Week Range: 248.88 to $630.73</li>
<li>Year-to-Date Return: -38.2%</li>
<li>2024 Benzinga Pro Search Rank: Not in Top 20</li>
<li>April/May/June 2025 Search Rank: Not in Top 20/5th/Not in Top 20</li>
</ul>
7. CoreWeave Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>)
<ul class="wp-block-list">
<li>Current Price: $163.06</li>
<li>52-Week Range: $33.52 to $187</li>
<li>Year-to-Date Return: +307.8%</li>
<li>2024 Benzinga Pro Search Rank: Not Public</li>
<li>April/May/June 2025 Search Rank: Not in Top 20/11th/6th</li>
</ul>
8. Super Micro Computer Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>)
<ul class="wp-block-list">
<li>Current Price: $49.01</li>
<li>52-Week Range: $17.25 to $96.33</li>
<li>Year-to-Date Return: +63.1%</li>
<li>2024 Benzinga Pro Search Rank: 4th</li>
<li>April/May/June 2025 Search Rank: 9th/Not in Top 20/Not in Top 20</li>
</ul>
9. Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>)
<ul class="wp-block-list">
<li>Current Price: $141.90</li>
<li>52-Week Range: $76.48 to $187.28</li>
<li>Year-to-Date Return: +17.6%</li>
<li>2024 Benzinga Pro Search Rank: 6th</li>
<li>April/May/June 2025 Search Rank: 18th/14th/9th</li>
</ul>
10. Oklo Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>)
<ul class="wp-block-list">
<li>Current Price: $55.99</li>
<li>52-Week Range: $5.35 to $73.55</li>
<li>Year-to-Date Return: +156.3%</li>
<li>2024 Benzinga Pro Search Rank: Not in Top 20</li>
<li>April/May/June 2025 Search Rank: Not in Top 20/12th/10th</li>
</ul>
Read Also: <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/07/46198021/nvidia-vs-microsoft-vs-apple-which-stock-reaches-4-trillion-first">Nvidia Vs. Microsoft Vs. Apple: Which Stock Reaches $4 Trillion First?</a>
Honorable Mentions:&nbsp;The following stocks were the 11th&nbsp;to 20th&nbsp;most-searched tickers on&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent030425&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>&nbsp;for the first six months of 2025.
11. Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)
12. Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>)
13. Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>)
14. Coinbase Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>)
15. Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>)
16. SharpLink Gaming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBET#NASDAQ">SBET</a>)
17. D-Wave Quantum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>)
18. Asset Entities (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASST#NASDAQ">ASST</a>)
19. Circle Internet Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRCL#NYSE">CRCL</a>)
20. Pony AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>)
Why It's Important: The top 10 list for the first six months of 2025 looked similar to the month of June, with eight of the companies the same.
UnitedHealth Group, which has appeared in only one top 20 over the past three months, ranked sixth thanks to the strong interest in the ticker at the start of the year.
Super Micro Computer similarly ranked eighth for the first half of 2025 despite only a ninth place rank in April and not being in the top 20 in May or June. The stock was particularly popular during the first three months of the year.
If the top 10 holds steady for the rest of the year, the top three stocks would match the 2024 year, but in a different order. In 2024, it was Nvidia ranked first, followed by Tesla and the SPDR S&amp;P 500 ETF Trust. The three stocks now rank in opposite order through the first six months of the year.
Outside of the top 10 there weren't many huge surprises with themes such as cryptocurrency, AI and quantum computing being strong in the first six months of 2025.
Apple ended the first half of the year ranked 12th, despite previously ranking in the top 10 in several months to start the year. Other Mag 7 stocks such as Amazon and Meta also ranked in the 11 to 20. Alphabet ranked just outside of the top 20 for the first half of the year at 22nd place. Nowhere to be found in the top 25 was Microsoft, a member of the Mag 7 and the second most valuable company in the world.
Stay tuned <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0702" target="_blank" rel="noreferrer noopener">to Benzinga Pro </a>for more market-moving news and to track the top tickers.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/large-cap/25/07/46200141/dow-jones-2025-first-half-scoreboard-top-10-winners-losers-where-do-nvidia-apple-stock-rank">Dow Jones 2025 First Half Scoreboard: Top 10 Winners, Losers — Where Do Nvidia, Apple Stock Rank?</a></li>
</ul>

Long Ideas

Exclusives

Trading Ideas

AAPL

AMZN

ASST

COIN

CRCL

CRWV

Hims & Hers Health, Inc. Class A Common Stock

HIMS

NVDA

OKLO

PLTR

PONY

QBTS

SBET

SMCI

TSLA

EXCLUSIVE: 2025's First Half Most-Searched Tickers On Benzinga Pro — Where Do Nvidia, Tesla, Apple Stock Rank?

UnitedHealth Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) is down a staggering 46% from its April peak of $630, and a troubling mix of leadership shake-ups, DOJ and CMS probes, and guidance withdrawals <a href="https://www.benzinga.com/quote/UNH/news">have weighed heavy</a>. 
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="583" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02141632/Screenshot-2025-07-02-at-7.04.05-PM-1024x583.png" alt="" class="wp-image-970914" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02141632/Screenshot-2025-07-02-at-7.04.05-PM-1024x583.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02141632/Screenshot-2025-07-02-at-7.04.05-PM-300x171.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02141632/Screenshot-2025-07-02-at-7.04.05-PM-768x437.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02141632/Screenshot-2025-07-02-at-7.04.05-PM.png 1143w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Source: TradingView
But amid the chaos, insiders — and surprisingly, members of Congress — are scooping up shares.
<h2 class="wp-block-heading">What's Dragging UNH?</h2>
UNH stock is down over 38% year-to-date, with its descent beginning in April. Factors that have contributed to the slide, include:
<ul class="wp-block-list">
<li>A <a href="https://www.benzinga.com/quote/UNH/earnings">massive earnings miss</a> and retreat on 2025 guidance, which triggered a 50% plunge from March highs.</li>
<li>Leadership turbulence didn't help: CEO Andrew Witty <a href="https://www.benzinga.com/25/05/45373368/unitedhealth-stock-plunges-names-new-ceo-suspends-2025-guidance">resigned</a>, and board chair Stephen Hemsley returned just days later.</li>
<li>Legal risks abound: <a href="https://www.benzinga.com/general/health-care/25/05/45426769/unitedhealth-stock-plunges-over-8-in-after-hours-trading-as-doj-criminal-probe-adds-to-turmoil-after-ceo-shake-up">DOJ criminal probes</a> and <a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46192421/home-health-braces-for-potential-1-billion-cut-in-medicare-payments">CMS Medicare Advantage</a> audits intensify.</li>
</ul>
Read Also: <a href="https://www.benzinga.com/politics/25/05/45530324/new-congressmans-first-stock-trade-tanks-45-after-betting-on-unitedhealth-before-fallout">New Congressman&#8217;s First Stock Trade Tanks 45% After Betting On UnitedHealth Before Fallout</a>
<h2 class="wp-block-heading">Government &amp; Insiders: Buying The Dip</h2>
In an unusual twist, Congress members like Texas Rep. Michael McCaul and Georgia Rep. Marjorie Taylor Greene have been <a href="https://www.capitoltrades.com/issuers/435467?page=1">buying UNH shares</a> worth thousands — even after the earnings crash.
Meanwhile, returning CEO Stephen Hemsley <a href="https://www.capitoltrades.com/issuers/435467?page=1">pumped in</a> $25 million, and other executives also invested heavily. Reddit even <a href="https://www.reddit.com/r/stocks/comments/1koekm0/unh_insiders_directors_and_executives_buy_over/">flagged</a> "[insiders] directors and executives <a href="https://www.secform4.com/insider-trading/731766.htm">buy</a> over $30 M of the beaten down stock.&#8221;
<h2 class="wp-block-heading">Technicals &amp; Valuation: A Mixed Bag</h2>
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0702"><img loading="lazy" decoding="async" width="624" height="488" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02143208/Screenshot-2025-07-03-at-12.01.57-AM.png" alt="" class="wp-image-970936" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02143208/Screenshot-2025-07-03-at-12.01.57-AM.png 624w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02143208/Screenshot-2025-07-03-at-12.01.57-AM-300x235.png 300w" sizes="(max-width: 624px) 100vw, 624px" /></a></figure>
<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0702">Chart created using Benzinga Pro</a>
UnitedHealth trades at $312.44, above its eight and 20-day SMAs (simple moving averages), signaling short-term buying interest. But it&#8217;s below the 50-day ($334.70) and 200-day ($491.61) SMAs, and the MACD (moving average convergence/divergence) is negative, suggesting the downtrend isn't over. The RSI (relative strength index) at 47.06 is neutral, leaving room for upside.
Valuation metrics—with P/E at~13.7, PEG ~0.87, EV/EBITDA ~9.4—seem to paint the picture of a deeply discounted insurer.
Is UNH's fall a value opportunity &#8211; or a warning? With politicians and insiders buying, there&#8217;s a strong signal that the dip might be nearing its end. 
But unresolved regulatory concerns and leadership instability could still derail recovery. Watch the 50-day SMA (~$334.70) as a potential pivot point. Close above it, and the bounce could gain steam; below, the pain might persist.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46192421/home-health-braces-for-potential-1-billion-cut-in-medicare-payments">Home Health Braces For Potential $1 Billion Cut In Medicare Payments</a></li>
</ul>
Image: Shutterstock

Health Care

Technicals

General

Congress Is Buying Into UnitedHealth's 46% Crash — What Do They Know That Wall Street Doesn't?

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Below are some instances of options activity happening in the Health Care sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>JNJ</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$157.50</td>
<td>$94.8K</td>
<td>1.5K</td>
<td>1.5K</td>
</tr>
<tr>
<td>MRNA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/11/25</td>
<td>$30.00</td>
<td>$25.7K</td>
<td>980</td>
<td>1.0K</td>
</tr>
<tr>
<td>CNC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$35.00</td>
<td>$29.5K</td>
<td>10</td>
<td>899</td>
</tr>
<tr>
<td>UNH</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$307.50</td>
<td>$37.3K</td>
<td>1.1K</td>
<td>437</td>
</tr>
<tr>
<td>SRPT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>11/21/25</td>
<td>$20.00</td>
<td>$37.7K</td>
<td>1.0K</td>
<td>431</td>
</tr>
<tr>
<td>PRME</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/17/25</td>
<td>$1.00</td>
<td>$27.5K</td>
<td>24</td>
<td>100</td>
</tr>
<tr>
<td>BMY</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/17/27</td>
<td>$60.00</td>
<td>$161.0K</td>
<td>827</td>
<td>100</td>
</tr>
<tr>
<td>HIMS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$1.00</td>
<td>$46.7K</td>
<td>14.6K</td>
<td>67</td>
</tr>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/21/25</td>
<td>$75.00</td>
<td>$26.5K</td>
<td>387</td>
<td>61</td>
</tr>
<tr>
<td>ELV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$340.00</td>
<td>$90.7K</td>
<td>11</td>
<td>56</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• Regarding JNJ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>), we observe a call option trade with bearish sentiment. It expires in 16 day(s) on July 18, 2025. Parties traded 465 contract(s) at a $157.50 strike. The total cost received by the writing party (or parties) was $94.8K, with a price of $204.0 per contract. There were 1504 open contracts at this strike prior to today, and today 1579 contract(s) were bought and sold. 
• For MRNA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>), we notice a call option sweep that happens to be bearish, expiring in 9 day(s) on July 11, 2025. This event was a transfer of 211 contract(s) at a $30.00 strike. This particular call needed to be split into 8 different trades to become filled. The total cost received by the writing party (or parties) was $25.7K, with a price of $122.0 per contract. There were 980 open contracts at this strike prior to today, and today 1094 contract(s) were bought and sold. 
• Regarding CNC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>), we observe a call option sweep with bullish sentiment. It expires in 198 day(s) on January 16, 2026. Parties traded 50 contract(s) at a $35.00 strike. This particular call needed to be split into 9 different trades to become filled. The total cost received by the writing party (or parties) was $29.5K, with a price of $590.0 per contract. There were 10 open contracts at this strike prior to today, and today 899 contract(s) were bought and sold. 
• For UNH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>), we notice a put option trade that happens to be bearish, expiring in 16 day(s) on July 18, 2025. This event was a transfer of 65 contract(s) at a $307.50 strike. The total cost received by the writing party (or parties) was $37.3K, with a price of $575.0 per contract. There were 1172 open contracts at this strike prior to today, and today 437 contract(s) were bought and sold. 
• For SRPT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>), we notice a put option trade that happens to be bearish, expiring in 142 day(s) on November 21, 2025. This event was a transfer of 65 contract(s) at a $20.00 strike. The total cost received by the writing party (or parties) was $37.7K, with a price of $580.0 per contract. There were 1022 open contracts at this strike prior to today, and today 431 contract(s) were bought and sold. 
• For PRME (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRME#NASDAQ">PRME</a>), we notice a call option trade that happens to be bullish, expiring in 107 day(s) on October 17, 2025. This event was a transfer of 100 contract(s) at a $1.00 strike. The total cost received by the writing party (or parties) was $27.5K, with a price of $275.0 per contract. There were 24 open contracts at this strike prior to today, and today 100 contract(s) were bought and sold. 
• For BMY (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>), we notice a put option trade that happens to be bullish, expiring in 898 day(s) on December 17, 2027. This event was a transfer of 100 contract(s) at a $60.00 strike. The total cost received by the writing party (or parties) was $161.0K, with a price of $1610.0 per contract. There were 827 open contracts at this strike prior to today, and today 100 contract(s) were bought and sold. 
• Regarding HIMS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>), we observe a call option trade with bearish sentiment. It expires in 198 day(s) on January 16, 2026. Parties traded 10 contract(s) at a $1.00 strike. The total cost received by the writing party (or parties) was $46.7K, with a price of $4673.0 per contract. There were 14663 open contracts at this strike prior to today, and today 67 contract(s) were bought and sold. 
• Regarding NVO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>), we observe a call option sweep with bullish sentiment. It expires in 142 day(s) on November 21, 2025. Parties traded 45 contract(s) at a $75.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $26.5K, with a price of $590.0 per contract. There were 387 open contracts at this strike prior to today, and today 61 contract(s) were bought and sold. 
• Regarding ELV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELV#NYSE">ELV</a>), we observe a call option sweep with bearish sentiment. It expires in 79 day(s) on September 19, 2025. Parties traded 24 contract(s) at a $340.00 strike. This particular call needed to be split into 11 different trades to become filled. The total cost received by the writing party (or parties) was $90.7K, with a price of $3768.0 per contract. There were 11 open contracts at this strike prior to today, and today 56 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

MRNA

PRME

SRPT

10 Health Care Stocks With Whale Alerts In Today's Session

UnitedHealth Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) shares are moving lower Wednesday in sympathy with Centene, which <a href="https://www.benzinga.com/markets/guidance/25/07/46209736/centene-withdraws-2025-guidance-shares-dive">withdrew its 2025 guidance</a>. 
What Happened: Late Tuesday, health insurer Centene warned that it expects earnings to come up short of prior expectations. The company withdrew its 2025 earnings per share guidance as a result.
Centene said that overall market growth in 22 of the company's 29 marketplace states was lower than previously expected based on the company's preliminary interpretation of marketplace data from independent actuarial firm Wakely.&nbsp;
Centene forecasted an estimated reduction of its previous full-year net risk adjustment revenue transfer&nbsp;expectations of approximately $1.8 billion, representing an adjusted earnings impact of approximately $2.75 per share.
United Health and other health insurer stocks moved lower alongside Centene. In May, United Health <a href="https://www.benzinga.com/25/05/45373368/unitedhealth-stock-plunges-names-new-ceo-suspends-2025-guidance">suspended</a> its 2025 guidance as care activity accelerated and broadened to more types of benefit offerings and medical costs remained higher than the company expected. 
Shares of Elevance and Humana were also moving lower at last check, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
United Health shares are down approximately 35% year-to-date amid rising medical costs. The company said on an earnings call earlier this year that even common procedures can cost up to four times more in the U.S. than in other countries.
CEO Andrew Witty stepped down as CEO in May and was replaced by Stephen Hemsley, who previously held the CEO role from 2006 to 2017. United Health has said it expects to return to growth in 2026. 
UNH Price Action: <a href="http://benzinga.com/quote/UNH">United Health shares</a> were down 2.18% at $319.02 at the time of publication Wednesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/health-care/25/06/46056665/unitedhealth-cvs-among-major-insurers-to-fast-track-prior-authorizations-will-it-cut-profits-even-more">UnitedHealth, CVS Among Major Insurers To Fast-Track Prior Authorizations: Will It Cut Profits Even More?</a></li>
</ul>
Photo: Ken Wolter/Shutterstock.com

Movers

United Health Stock Is Sliding Today: What's Going On?

<ul>
<li>TSLA</li>
<li>NVDA</li>
<li>GLD</li>
<li>GOOGL</li>
<li>UNH</li>
<li>BULL</li>
<li>ADP</li>
<li>HOOD</li>
<li>AAPL</li>
<li>AMD</li>
</ul>
Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

BULL

GOOGL

HOOD

Top 10 Trending Stocks On WallStreetBets As Of July 2, 2025 (Via Swaggy Stocks)

WIIM

Shares of health insurance stocks are trading lower in sympathy with Centene, which withdrew its 2025 guidance.

Major U.S. indices were mixed on Tuesday, with the Dow Jones Industrial Average rising 0.9% to 44,494.94 and the S&amp;P 500 declining 0.1% to 6,198.01. The Nasdaq fell 0.8% to 20,202.89.
These are the top stocks that gained the attention of retail traders and investors throughout the day:
UnitedHealthcare Group Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>)
UnitedHealthcare closed the day with a gain of 4.54%, trading at $326.14. The stock&#8217;s intraday high was $326.55, while it hit a low of $311.08. Over the past 52 weeks, the stock has ranged from $248.88 to $630.73. UnitedHealthcare recently announced a multi-year agreement with Memorial Sloan Kettering (MSK), ensuring continued network access to MSK for people enrolled in UnitedHealthcare and Oxford employer-sponsored commercial plans.
Gryphon Digital Mining Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRYP#NASDAQ">GRYP</a>)
Gryphon Digital Mining saw a 2.26% increase, ending the day at $0.90. The stock reached an intraday high of $0.95 and a low of $0.85. Its 52-week high and low stand at $2.93 and $0.13. In the after-hours trading, the stock shot up nearly 60% to $1.44. The company, along with American Bitcoin Corp., <a href="https://www.benzinga.com/pressreleases/25/07/n46209107/american-bitcoin-and-gryphon-digital-mining-advance-toward-public-listing-of-american-bitcoin-with">filed</a> an amended registration statement with the U.S. Securities and Exchange Commission, advancing towards a public listing of American Bitcoin, a Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) accumulation platform.
See Also:&nbsp;<a href="https://benzinga.com/markets/equities/25/07/46187311/trump-says-elon-musk-would-close-up-shop-and-head-back-home-to-south-africa-without-subsidies-no" target="_blank" rel="noreferrer noopener">Trump Says Elon Musk Would &#8216;Close Up Shop And Head Back Home To South Africa&#8217; Without Subsidies: &#8216;No More Rocket Launches, Satellites, Or Electric Car&#8217;</a>
AMC Entertainment Holdings Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>)
AMC Entertainment&#8217;s stock slid by 9.03% to close at $2.82. The stock&#8217;s intraday high and low were $2.93 and $2.79, with a 52-week range of $2.45 to $5.76. The company <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46202505/amc-entertainment-stock-is-sliding-tuesday-whats-going-on">entered</a> into a Transaction Support Agreement with creditors to strengthen its balance sheet.
Centene Corporation&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>)
Centene&#8217;s stock rose by 4.37% to close at $56.65. The stock hit an intraday high of $57.46 and a low of $54.23. Its 52-week high and low are $80.59 and $52.93. The healthcare company <a href="https://www.benzinga.com/markets/guidance/25/07/46209736/centene-withdraws-2025-guidance-shares-dive">withdrew</a> its guidance for 2025, causing its shares to tumble nearly 25% in the after-hours session to $42.70.
Tesla Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)
Tesla&#8217;s shares fell by 5.34% to close at $300.71. The stock&#8217;s intraday high and low were $305.89 and $293.21, with a 52-week range of $182 to $488.54. The electric vehicle maker&#8217;s shares <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46206369/whats-going-on-with-tesla-shares-today-2">dropped</a> amid disagreements between CEO Elon Musk and President Donald Trump, and a decline in Tesla registrations in Sweden and Denmark during June.
Benzinga's Edge Stock Rankings indicate AMC checks out on Short, Medium and Long Price Trends. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Find out</a> how GameStop compares.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="447" height="281" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01214044/Screenshot-2025-07-02-at-10.40.28.png" alt="" class="wp-image-969448" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01214044/Screenshot-2025-07-02-at-10.40.28.png 447w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01214044/Screenshot-2025-07-02-at-10.40.28-300x189.png 300w" sizes="(max-width: 447px) 100vw, 447px" /></a></figure>
Prepare for the day&#8217;s trading&nbsp;<a href="https://editorial.benzinga.com/wp-admin/Premarket%20Movers%20&amp;%20News">with top premarket movers and news</a>&nbsp;by Benzinga.
Photo Courtesy: Sittipong Phokawattana from Shutterstock
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/25/07/46211529/cathie-wood-doubles-down-on-tesla-amid-elon-musks-feud-with-trump-sells-3-million-worth-of-coinbase-stock">Cathie Wood Doubles Down On Tesla Amid Elon Musk&#8217;s Feud With Trump, Sells $3 Million Worth Of Coinbase Stock</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

Equities

$BTC

GRYP

UnitedHealthcare Group, Gryphon Digital Mining, AMC Entertainment, Centene, And Tesla: Why These 5 Stocks Are On Investors' Radars Today

The <a href="https://www.benzinga.com/topic/dow-jones-industrial-average">Dow Jones Industrial Average</a> was up around 4% in the first half of 2025, with 21 of the 30 components positive year-to-date through the first six months.
The index, which contains a diverse basket of stocks across sectors, offers many dividend stocks, with some having high yields for investors.
What Happened: When looking <a href="https://www.benzinga.com/dividends">for dividend stocks</a>, the Dow Jones Industrial Average is one place with the index having a basket of what are considered blue-chip American companies.
The 30 index components have strong track records of revenue and earnings growth, and in many cases, a long history of paying dividends and raising the dividend amounts.
While investors can buy an ETF like the SPDR Dow Jones Industrial Average ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>), which tracks the entire index, another option is to buy the &#8220;Dogs of the Dow.&#8221;
The "Dogs of the Dow" is a popular strategy that often coincides with the beaten-down stocks of the index which also offer high dividend payouts.
Here are the current top-yielding dividend stocks in the Dow Jones Industrial Average after the first six months of 2025.
<ol class="wp-block-list">
<li>Verizon Communications Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>): 6.3%</li>
<li>Chevron Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>): 4.8%</li>
<li>Merck &amp; Co Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>): 4.1%</li>
<li>Amgen Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>): 3.4%</li>
<li>Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>): 3.4%</li>
<li>Coca-Cola Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>): 2.9%</li>
<li>UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>): 2.8%</li>
<li>Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>): 2.7%</li>
<li>Home Depot Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>): 2.5%</li>
<li>McDonald's Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>): 2.4%</li>
</ol>
In the Dow Jones Industrial Average, 28 of the 30 stocks pay out dividends. The average dividend yield of the 30 companies is 2% with the 10 highest averaging a yield of 3.5%.
Twenty of the 30 stocks in the index pay out at least a 1% dividend yield based on current stock prices.
Read Also: <a href="https://www.benzinga.com/markets/large-cap/25/07/46200141/dow-jones-2025-first-half-scoreboard-top-10-winners-losers-where-do-nvidia-apple-stock-rank">Dow Jones 2025 First Half Scoreboard: Top 10 Winners, Losers — Where Do Nvidia, Apple Stock Rank?</a>
Why It's Important: Along with stock price gains, dividends can be a nice form of consistent growth for companies and investors.
Investors can choose to collect dividend yield and put the capital to work in other stocks, or use it as income for other investments or spending. Investors can also reinvest the dividends back into the companies from which they got dividends.
Over a long period of time, dividend stocks can offer strong returns for investors with yields sometimes outpacing the returns of the overall stock market or other asset classes such as bonds and treasuries.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/best-monthly-dividend-stocks">Best Monthly Dividend Stocks</a></li>
</ul>
Photo: Shutterstock

Education

Dividends

AMGN

SPDR Dow Jones Industrial Average ETF Trust

Dogs Of The Dow: How You Can Get Dividend Stocks With Yields Up To 6.3%

The first half of 2025 has come to a close and 21 of the 30 stocks that make up the <a href="https://www.benzinga.com/topic/dow-jones-industrial-average">Dow Jones Industrial Average Index</a> are positive year-to-date.
Despite the impressive number of stocks with a positive performance in the first six months, the index was up around 4% with several of the components posting large declines.
2025 Performance: Through the first six months of the year, two <a href="https://www.benzinga.com/topic/magnificent-seven">Magnificent Seven stocks </a>are among the 10 best in the Dow Jones Industrial Average and two are among the 10 worst in the index based on performance.
Here's a look at the 10 best Dow Jones Industrial Average stocks in the first half:
<ol class="wp-block-list">
<li>International Business Machines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>): +34.1%</li>
<li>Goldman Sachs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>): +23.6%</li>
<li>JPMorgan Chase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>): +20.9%</li>
<li>Boeing Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>): +18.4%</li>
<li>Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>): +18.0%</li>
<li>3M Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>): +17.9%</li>
<li>NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>): +17.6%</li>
<li>Cisco Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>): +17.2%</li>
<li>Coca-Cola Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>): +13.6%</li>
<li>Visa Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>): +12.3%</li>
</ol>
Here are the 10 worst performing Dow Jones Industrial Average stocks in the first half:
<ol class="wp-block-list">
<li>UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>): -38.3%</li>
<li>Merck &amp; Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>): -20.4%</li>
<li>Salesforce.com Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>): -18.4</li>
<li>Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>): -18.1%</li>
<li>Nike Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>): -6.1%</li>
<li>Home Depot Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>): -5.7%</li>
<li>Procter &amp; Gamble Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>): -5.0%</li>
<li>Chevron Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>): -1.1%</li>
<li>Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>): Flat</li>
<li>McDonald's Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NASDAQ">MCD</a>): +0.8%</li>
</ol>
Overall the SPDR Dow Jones Industrial Average ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>), which tracks the index, was up around 4% in the first half of 2025. This was a lower gain than the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), which tracks the S&amp;P 500, which had a 5.7% gain in the first half.
Read Also: <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/06/45932660/exclusive-sp-500-new-all-time-highs-again-2025">EXCLUSIVE: S&amp;P 500 To Hit New All-Time Highs Again In 2025? Majority Say Yes, 27% Predict This Range</a>
Why It's Important: Nvidia was one of the new Dow Jones components <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/24/12/42726598/dow-jones-2024-scoreboard-top-5-winners-losers-and-how-amazon-nvidia-could-reshape-2025">added in 2024</a> and the stock is one of the top performers in the first half of 2025. The stock replaced Intel, which was a top decliner in recent years.
The index also got rid of Walgreens, which was another poor performer in recent years. Its replacement Amazon was flat for the first half of 2025.
The new index makeup is showing strong signs of positive returns.
With 21 of the components positive year-to-date and one flat, this could mark one of the best years by the number of gainers in recent history.
In 2024, 18 of the 30 stocks were up for the full year. In 2023, 19 of the stocks in the index were up.
Perhaps most surprising is that two of the Magnificent Seven stocks rank among the worst performers in the first half of 2025, despite being part of the four Mag 7 members included in the Dow Jones Industrial Average.
Apple was the fourth-worst performer in the index for the first half, falling 18.1%. That marks a sharp reversal from its standout status as the only Dow Jones stock to rank among the top gainers in both 2023 and 2024.
Amazon ranked ninth with a flat return, as only eight of the components were down. 
The Dow Jones Industrial Average remains one of the most closely watched stock market indexes, serving as a gauge of overall market health. With only 30 stocks and a weighting based on stock price, rather than market capitalization, the index is less frequently used by some analysts and market experts than the broader S&amp;P 500 Index.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/07/46198021/nvidia-vs-microsoft-vs-apple-which-stock-reaches-4-trillion-first">Nvidia Vs. Microsoft Vs. Apple: Which Stock Reaches $4 Trillion First?</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Large Cap

CSCO

MSFT

Dow Jones 2025 First Half Scoreboard: Top 10 Winners, Losers — Where Do Nvidia, Apple Stock Rank?

The Department of Justice, more than 320 individuals have been charged, uncovering nearly $15 billion in fraudulent claims, marking a significant milestone in the fight against healthcare fraud.
What Happened: The Justice Department announced the charges on Monday, revealing a staggering&nbsp;$14.6 billion in fraudulent claims. The operation, named &#8220;Operation Gold Rush,&#8221; also resulted in the seizure of assets worth over $245 million, including cash, luxury vehicles, and cryptocurrency.
The crackdown uncovered perpetrators operating from Russia, Eastern Europe, Pakistan, and several other countries. &nbsp;&#8220;These&nbsp;criminals didn't just steal someone&nbsp;else's money. They stole from&nbsp;you,&#8221; stated&nbsp;Matthew Galeotti, head of the Justice Department's criminal division. Approximately 100 licensed medical professionals, including 25 doctors, have been charged. The government has reported actual losses totaling $2.9 billion. Among the cases is a $10 billion urinary catheter scheme, underscoring the growing sophistication of transnational criminal organizations.
The scheme used stolen identities and personal information of over one million Americans, according to the Justice Department. 
The fraud, surpassing the previous record in the Justice Department's annual health care fraud crackdown, involves nearly 190 federal cases and more than 90 state cases that have been charged or unsealed since June 9.
SEE ALSO:&nbsp;<a href="https://benzinga.com/markets/macro-economic-events/25/07/46188192/trump-administration-reportedly-scales-back-ambitions-for-comprehensive-trade-deals" target="_blank" rel="noreferrer noopener">Trump Administration Reportedly Scales Back Ambitions For Comprehensive Trade Deals Before Tariff Deadline</a>
Why It Matters: This crackdown on health care fraud comes months after a <a href="https://www.benzinga.com/25/02/43879859/doj-investigates-unitedhealth-probe-accuses-of-inflating-medicare-diagnoses">civil fraud investigation</a> into UnitedHealth Group Inc.&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) Medicare billing practices by the Justice Department. The probe, which began in recent months, is set to examine UnitedHealth&#8217;s Medicare Advantage plans and physician groups following reports that the company received billions in federal payments for questionable diagnoses.
Moreover, this development is in line with the efforts to combat Medicare fraud, as outlined in Rep.&nbsp;Ro Khanna&#8216;s (D-Calif.) &#8220;Progressive Deficit Reduction Plan.&#8221; The plan, which was&nbsp;backed by billionaire investor <a href="https://www.benzinga.com/markets/macro-economic-events/25/06/45900891/mark-cuban-backs-ro-khannas-12-trillion-progressive-deficit-reduction-plan-targeting-medicare-fraud-and-military-spending">Mark Cuban</a>, aims to slash the U.S. deficit by $12 trillion over the next decade, with a significant portion of the spending cuts targeted at Medicare fraud.
<ul class="wp-block-list">
<li>READ MORE: <a href="https://www.benzinga.com/news/health-care/25/06/46056665/unitedhealth-cvs-among-major-insurers-to-fast-track-prior-authorizations-will-it-cut-profits-even-more">UnitedHealth, CVS Among Major Insurers To Fast-Track Prior Authorizations: Will It Cut Profits Even More?</a> </li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

DOJ Dismantles $14 Billion Healthcare Fraud Scheme In Largest-Ever Crackdown, Impacting Over 1 Million Americans

The Centers for Medicare &amp; Medicaid Services (CMS) released a proposed rule on Monday outlining changes to how Medicare pays home health agencies (HHAs) in <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">calendar year (CY) 2026</a>.
These updates are required by law and occur annually.
The <a target="_blank" href="https://www.cms.gov/newsroom/fact-sheets/calendar-year-cy-2026-home-health-prospective-payment-system-proposed-rule-fact-sheet-cms-1828-p#:~:text=For%20the%20CY%202026%20HH,30%2Dday%20base%20payment%20rate." rel="noreferrer noopener">rule</a> includes a routine payment increase of 2.4%, which would add about $425 million in funding. However, three other proposed changes would reduce payments:
<ul class="wp-block-list">
<li>A permanent behavior adjustment would cut payments by about 3.7% ($655 million),</li>
<li>A temporary adjustment would reduce payments by 4.6% ($815 million),</li>
<li>A change to the outlier payment formula (FDL ratio) would result in an additional 0.5% ($90 million) reduction.</li>
</ul>
Overall, CMS estimates that total Medicare payments to home health agencies in 2026 will decrease by 6.4%, or approximately $1.135 billion, compared to 2025.
<h2 class="wp-block-heading">Stock In Focus</h2>
Specific to its coverage, William Blair notes that home health accounts for roughly 5% of Addus HomeCare Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADUS#NASDAQ">ADUS</a>) revenue and roughly 63% of Amedisys Inc&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMED#NASDAQ">AMED</a>) revenue (Amedisys is in the <a href="https://www.benzinga.com/general/health-care/24/11/41987383/unitedhealths-optum-defends-multi-billion-dollar-amedisys-deal-ensures-competitive-landscape" target="_blank" rel="noreferrer noopener">process of being</a> acquired by UnitedHealth Inc&#8216;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/unh#NYSE">UNH</a>) Optum.
<h2 class="wp-block-heading">Addus HomeCare</h2>
&#8220;In our view, Addus presents one of the few opportunities for public equity investors to gain exposure to the in-home care delivery theme, with a particular emphasis on nonmedical care,&#8221; William Balir wrote in an investor note on Monday.
Also Read: <a target="_blank" href="https://www.benzinga.com/24/12/42515091/home-based-health-service-provider-addus-homecare-is-well-positioned-to-grow-analyst" rel="noreferrer noopener">As US Faces Shortage Of Expensive Skilled Clinicians, Home-Based Health Service Provider Addus HomeCare Is Well-Positioned To Grow: Analyst</a>
Analyst Matt Larew views the company's differentiated position in the marketplace as supporting strong growth characteristics, which are expected to be at the high end of management's typical 3% to 5% organic baseline target. William Blair maintains an Outperform rating.
<h2 class="wp-block-heading">Amedisys</h2>
&#8220;We believe that Amedisys is well-positioned to take advantage of strong secular tailwinds that should support total volume growth in the company's markets (home health, hospice, and personal care) at least in the mid single digits for the next decade-plus,&#8221; the analyst wrote.
Amedisys' focus on quality and its well-rounded approach to in-home care position it to benefit more than most from the market's growth. However, in the short term, its stock will likely be influenced by labor trends, hospice recovery, home health payments, and the growth of its Contessa unit.
Looking further ahead, Amedisys is on track to become a top player in aging-in-place care. Through its mix of clinical expertise, technology, and on-the-ground staff, it will help insurers reduce costs and improve patient outcomes.
Price Action: ADUS closed at $115.19 on Monday. AMED stock is down 0.2% at $98.11 during the premarket session at the last check on Tuesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/06/46109624/rfk-jr-overhauls-cdc-vaccine-panel-sparking-expert-backlash-boycott-from-top-medical-group" target="_blank" rel="noreferrer noopener">RFK Jr. Overhauls CDC Vaccine Panel, Sparking Expert Backlash, Boycott From Top Medical Group</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Government

Regulations

Analyst Ratings

ADUS

AMED

Home Health Braces For Potential $1 Billion Cut In Medicare Payments

On CNBC's &#8220;<a href="https://www.cnbc.com/video/2025/06/30/final-trades-applied-materials-unitedhealth-mercado-libre.html">Halftime Report Final Trades</a>,&#8221; Jim Lebenthal at Cerity Partners named Applied Materials, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>) <a href="https://www.benzinga.com/quote/AMAT/analyst-ratings">as his final trade.</a>
Supporting his view, Cantor Fitzgerald analyst Matthew Prisco maintained an Overweight rating for Applied Materials on June 24, raising the price target from $200 to $220.
Stephen Weiss, chief investment officer and managing partner of Short Hills Capital Partners, picked UnitedHealth Group Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>).
Lending support to his choice, JP Morgan analyst Lisa Gill maintained a UnitedHealth Group rating of Overweight on June 20 and raised the price target from $405 to $418.
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
Joseph M. Terranova is a senior managing director for Virtus Investment Partners, named MercadoLibre, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>) as his final trade.
Supporting his choice, Susquehanna analyst James Friedman, on June 26, maintained a Positive rating for MercadoLibre and raised the price target from $ 2,840 to $ 2,975.
Price Action:
<ul class="wp-block-list">
<li>Applied Materials shares fell 0.1% to close at $183.07 on Monday.</li>
<li>UnitedHealth Group rose 0.9% to settle at $311.97 during the session.</li>
<li>MercadoLibre shares gained 2.1% to settle at $2,613.63 on Monday.</li>
</ul>
Check This Out: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/06/46169288/5-stocks-in-the-spotlight-wall-streets-most-accurate-analysts-weigh-in">5 Stocks In The Spotlight: Wall Street&#8217;s Most Accurate Analysts Weigh In</a></li>
</ul>
Photo: Shutterstock

Media

AMAT

MELI

MercadoLibre, Applied Materials And A Healthcare Stock On CNBC's 'Final Trades'

UnitedHealth Group's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) short percent of float has risen 8.33% since its last report. The company recently reported that it has 11.75 million shares sold short, which is 1.3% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>UnitedHealth Group Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751306429_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for UnitedHealth Group has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing UnitedHealth Group's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, UnitedHealth Group's peer group average for short interest as a percentage of float is 5.21%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Do Investors Really Feel About UnitedHealth Group?

CNBC Halftime Report Final Trades: UnitedHealth Group, MercadoLibre, Applied Materials

<a href="https://www.reuters.com/legal/litigation/us-supreme-court-expected-rule-obamacare-preventive-care-task-force-2025-06-27/" title="https://www.reuters.com/legal/litigation/us-supreme-court-expected-rule-obamacare-preventive-care-task-force-2025-06-27/">https://www.reuters.com/legal/litigation/us-supreme-court-expected-rule-obamacare-preventive-care-task-force-2025-06-27/</a>
&nbsp;

ALHC

CLOV

'US Supreme Court preserves key element of Obamacare preventive care'- Reuters

<a href="https://x.com/dorajfacundo/status/1937954599601623118" title="https://x.com/dorajfacundo/status/1937954599601623118">https://x.com/dorajfacundo/status/1937954599601623118</a>

Legal

Capital Forum Reporter Jarod Facundo Posts On X 'EXCLUSIVE - DOJ Antitrust leadership is considering changing the direction of its ongoing investigation into UnitedHealth Group to focus on the company's PBM, inspired by President Trump's drug pricing executive order and comments criticizing health care "middlemen."'

UBS analyst Kevin Caliendo maintains UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) with a Buy and lowers the price target from $400 to $385.

Price Target

UBS Maintains Buy on UnitedHealth Group, Lowers Price Target to $385

UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) today announced that it recently became aware of an unsolicited "mini-tender" offer by Tutanota LLC (Tutanota) to purchase up to 175,000 shares of UnitedHealth Group's common stock, representing significantly less than 1% of UnitedHealth Group's common stock outstanding.
The offer price of $325.00 per share is conditioned on, among other things, the closing price per share of UnitedHealth Group's common stock exceeding $325.00 per share on the last full trading day before the offer expires. This means that unless this condition is waived by Tutanota, UnitedHealth Group shareholders who tender their shares in the offer will receive a below-market price. Tutanota further states in its offering documents that it expects to extend the offer for successive periods of 45 to 180 days until the market price of the shares exceeds the offer price.
UnitedHealth Group recommends that shareholders do not tender their shares in response to Tutanota's offer because the offer is at a price below a conditional market price for UnitedHealth Group's common stock and subject to numerous additional conditions. Shareholders who have already tendered their shares may withdraw them at any time by providing notice in the manner described in the Tutanota offering documents prior to the expiration of the offer, which is currently scheduled for 5 p.m. EDT, on Monday, June 23, 2025, unless extended or earlier terminated.
UnitedHealth Group does not endorse Tutanota's unsolicited mini-tender offer and is not associated in any way with Tutanota, its mini-tender offer, or its mini-tender offer documents.

UnitedHealth Urges Shareholders To Reject Tutanota "Mini-Tender" Offer Over Undervalued Terms, Added Conditions

<a href="https://www.wsj.com/politics/policy/lawmakers-seek-to-close-va-loophole-that-funnels-billions-to-private-medicare-insurers-cfbe0b19">https://www.wsj.com/politics/policy/lawmakers-seek-to-close-va-loophole-that-funnels-billions-to-private-medicare-insurers-cfbe0b19</a>

ELEV

'Lawmakers Seek to Close VA Loophole That Funnels Billions to Private Medicare Insurers'- WSJ

Press Releases

UnitedHealth Group Updates on Annual Shareholder Meeting, Board Actions

AM Best Revises Outlooks to Negative for UnitedHealth Group Incorporated and Its Subsidiaries

UNH INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that UnitedHealth Group Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in UnitedHealth Group Incorporated of Class Action Lawsuit and Upcoming Deadlines - UNH

UNITEDHEALTH ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against UnitedHealth Group Incorporated and Encourages Investors to Contact the Firm

UnitedHealth Group Recommends Shareholders Reject "Mini-Tender" Offer by Tutanota

AM Best Assigns Issue Credit Ratings to UnitedHealth Group Incorporated's New Senior Unsecured Notes

UnitedHealth Group Incorporated Investors: Please contact the Portnoy Law Firm to recover your losses. July 7, 2025 Deadline to file Lead Plaintiff Motion

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against UnitedHealth, Bitfarms, and Reddit and Encourages Investors to Contact the Firm

UnitedHealth Group Incorporated Investor Alert (NYSE: UNH): Schubert Jonckheer & Kolbe LLP Investigating Potential Shareholder Claims Against the Company's Officers and Directors Following DOJ Probe and for Possible False Statements

Comments

UnitedHealth Group

Unusual Options Activity for

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

Date	Put/Call	Strike Price	Exp Date	DTE	Trade Vol	Day Vol	Vol / OI	OI	Trade Type	Sentiment
02:58 PMJun 27, 2025	CALL	$300.00	Mar 20, 2026	258	6063	250	222	2725	SWEEP	BEARISH
02:58 PMJun 27, 2025	CALL	$300.00	Mar 20, 2026	258	5063	500	186	2725	TRADE	NEUTRAL
02:58 PMJun 27, 2025	CALL	$300.00	Mar 20, 2026	258	4063	500	149	2725	TRADE	NEUTRAL
02:58 PMJun 27, 2025	CALL	$300.00	Mar 20, 2026	258	3563	500	131	2725	TRADE	NEUTRAL
02:38 PMJun 27, 2025	CALL	$300.00	Mar 20, 2026	258	1556	500	57	2725	TRADE	BULLISH
03:05 PMJun 26, 2025	PUT	$290.00	Dec 17, 2027	895	121	120	576	21	TRADE	NEUTRAL
09:55 AMJun 24, 2025	PUT	$500.00	Dec 19, 2025	167	41	41	38	108	SWEEP	BULLISH
11:51 AMJun 23, 2025	CALL	$350.00	Jun 18, 2026	348	733	700	48	1525	TRADE	BEARISH
03:50 PMJun 20, 2025	PUT	$550.00	Sep 19, 2025	76	80	80	444	18	TRADE	NEUTRAL
03:50 PMJun 20, 2025	PUT	$430.00	Jul 18, 2025	13	103	70	187	55	TRADE	NEUTRAL
03:50 PMJun 20, 2025	PUT	$510.00	Aug 15, 2025	41	130	130	419	31	TRADE	NEUTRAL
03:50 PMJun 20, 2025	PUT	$500.00	Aug 15, 2025	41	120	120	400	30	TRADE	NEUTRAL
03:50 PMJun 20, 2025	PUT	$540.00	Sep 19, 2025	76	1180	1180	459	257	TRADE	NEUTRAL
03:50 PMJun 20, 2025	PUT	$580.00	Sep 19, 2025	76	150	150	385	39	TRADE	NEUTRAL
03:50 PMJun 20, 2025	PUT	$610.00	Jan 16, 2026	195	190	190	633	30	TRADE	NEUTRAL
03:40 PMJun 20, 2025	PUT	$520.00	Jul 18, 2025	13	34	34	680	5	TRADE	BULLISH
02:02 PMJun 20, 2025	PUT	$480.00	Jan 16, 2026	195	110	45	14	776	TRADE	NEUTRAL
12:03 PMJun 20, 2025	PUT	$480.00	Jan 16, 2026	195	60	49	8	776	TRADE	BULLISH